CCL2 and prostate carcinoma: The CCL2 ELISA data showed that autocrine CCL2 levels were significantly increased in the selected mig cells with increased in vitro migration ability (Figure 3A), implicating increased autocrine production of CCL2 by prostate cancer cells as a key step in the promotion of prostate cancer cell migration.